Type
Business expansion
Country
United Kingdom
Region
East of England; Bedfordshire and Hertfordshire; Hertfordshire
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

500 jobs
Number of planned job creations
Job creation
Announcement Date
24 January 2006
Employment effect (start)
Foreseen end date

Description

Japanese pharmaceutical company Eisai said it was building a £75 million research and manufacturing centre in Hertfordshire which would create 500 jobs. Eisai, one of the world's top 20 pharmaceutical companies, already has a research and development facility at University College London. But the new Hatfield plant will be the first time a Japanese pharmaceutical company has opened a manufacturing facility in the UK.

Trade minister Ian Pearson said the Amgen and Eisai decisions in January 2006 demonstrated Britain's attractiveness as a location for pharmaceutical and biotech companies. 'These two significant investments reinforce the UK's position as having the largest biotech sector in Europe. Both the Amgen and Eisai investments show that our research and development capability is truly world class.'


Sources

  • 25 January 2006: The Guardian

Citation

Eurofound (2006), Eisai, Business expansion in United Kingdom, factsheet number 62822, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/62822.